scholarly journals Lowering Intraocular Pressure: A Potential Approach for Controlling High Myopia Progression

2021 ◽  
Vol 62 (14) ◽  
pp. 17
Author(s):  
Peiyuan Wang ◽  
Shida Chen ◽  
Yaoming Liu ◽  
Fengbin Lin ◽  
Yunhe Song ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
High Myopia ◽  
Myopia Progression ◽  
Potential Approach

scholarly journals Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

2021 ◽  
pp. 112067212199896
Author(s):  
János Németh ◽  
Beáta Tapasztó ◽  
Wagih A Aclimandos ◽  
Philippe Kestelyn ◽  
Jost B Jonas ◽  
...  
Keyword(s):  
European Society ◽  
High Myopia ◽  
Treatment Options ◽  
Vision Impairment ◽  
Pathological Myopia ◽  
Myopia Progression ◽  
Preventive Actions ◽  
Prevalence Estimates ◽  
Number Of Individuals ◽  
Myopia Control

The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.

scholarly journals Myopia progression from wearing first glasses to adult age: the DREAM Study

2021 ◽  
pp. bjophthalmol-2020-316234
Author(s):  
Jan Roelof Polling ◽  
Caroline Klaver ◽  
Jan Willem Tideman
Keyword(s):  
Retrospective Study ◽  
The Netherlands ◽  
Refractive Error ◽  
High Myopia ◽  
Prognostic Indicator ◽  
Treatment Intensity ◽  
Spherical Equivalent ◽  
Inclusion Criteria ◽  
Myopia Progression ◽  
Adult Age

PurposeData on myopia progression during its entire course are scarce. The aim of this study is to investigate myopia progression in Europeans as a function of age and degree of myopia from first prescription to final refractive error.MethodsThe Drentse Refractive Error and Myopia Study assessed data from a branch of opticians in the Netherlands from 1985 onwards in a retrospective study. First pair of glasses prescribed was defined as a spherical equivalent of refraction (SER) ≤−0.5 D to ≥−3.0 D. Subjects with prescriptions at an interval of at least 1 year were included in the analysis.ResultsA total of 2555 persons (57.3% female) met the inclusion criteria. Those with first prescription before the age of 10 years showed the strongest progression (−0.50 D; IQR: −0.75 to −0.19) and a significantly (p<0.001) more negative median final SER (−4.48 D; IQR: −5.37 to −3.42). All children who developed SER ≤−3 D at 10 years were highly myopic (SER ≤−6D) as adults, children who had SER between −1.5 D and −3 D at 10 years had 46.0% risk of high myopia, and children with SER between −0.5 D and −1.5 D had 32.6% risk of high myopia. Myopia progression diminished with age; all refractive categories stabilised after age 15 years except for SER ≤−5 D who progressed up to −0.25 D annually until age 21 years.ConclusionOur trajectories of the natural course of myopia progression may serve as a guide for myopia management in European children. SER at 10 years is an important prognostic indicator and will help determine treatment intensity.

Clinical Profile of Myopic Patients as a Risk Factor for Primary Open Angle Glaucoma - A Prospective Observational Study in Gorakhpur, Uttar Pradesh

2021 ◽  
Vol 8 (33) ◽  
pp. 3084-3089
Author(s):  
Ram Kumar Jaiswal ◽  
Ramyash Singh Yadav ◽  
Mridula Ranjan ◽  
Dipti Wahi ◽  
Chiranji Rai
Keyword(s):  
Risk Factor ◽  
Intraocular Pressure ◽  
Observational Study ◽  
High Myopia ◽  
Central Corneal Thickness ◽  
Prospective Observational Study ◽  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
Corneal Thickness ◽  
Open Angle

BACKGROUND Myopia is a complex trait including both genetic and environmental factors as well as gene-environment interactions. It has been recognized as a risk factor for development of glaucoma. Both Myopia and raised IOP are known to increase mechanical stress at optic nerve head leading to glaucomatous nerve damage. This study intends to evaluate the clinical profile of myopic subjects and its correlation with Primary open angle glaucoma (POAG). METHODS A prospective observational study done from November 2019 to December 2020 after taking proper informed consent and ethical clearance. 164 eyes of 96 patients studied were divided into three groups, Group 1: low myopia (< -3.00D), Group 2: moderate myopia (-3.00 D to -5.75 D), Group 3: high myopia (≥ -6.00 D). A complete ocular examination was performed. Intraocular pressure was measured using Goldmann applanation tonometer. Visual field analysis using Humphrey automated perimetry was done in patients with suspected primary open angle glaucoma (POAG). Angle parameters and central corneal thickness (CCT) were measured using anterior segment optical coherence tomography (AS-OCT). RESULTS 164 eyes of 96 Myopic subjects were studied with no dropout during study period. Mean age was 46.05 yr. (range: 25-75 yr.). The refraction ranged from -0.50 DS to -17.00 DS. There was no statistically significant difference between Intraocular pressure (IOP), Central corneal thickness (CCT), corrected IOP and Nasal and Temporal Trabecular-iris Angle (TIA) between male and female of same age group. Mean IOP and mean CCT were found to vary significantly with age and with higher degree of myopia. Corrected IOP, Nasal and Temporal TIA increase significantly with higher degree of myopia. Cup-disc ratio (CDR) was found to be significantly higher in patients with moderate to high degree of Myopia. CONCLUSIONS Myopia is an important risk factor for development of primary open angle glaucoma, with its incidence increasing in patients with moderate to high myopia. KEYWORDS Myopia, Primary Open Angle Glaucoma, Intraocular Pressure, Central Corneal Thickness, Trabecular Iris Angle

scholarly journals Endothelin-1 Serum Concentration is Lower in Children and Adolescents with High Myopia, a Preliminary Study

2020 ◽  
Vol 9 (5) ◽  
pp. 1327
Author(s):  
Katarzyna Powierza ◽  
Beata Żelazowska-Rutkowska ◽  
Jolanta Sawicka-Powierza ◽  
Bożena Mikołuć ◽  
Beata Urban ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Axial Length ◽  
High Myopia ◽  
Cross Sectional Study ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Concentrations ◽  
Myopia Progression ◽  
Cross Sectional ◽  
Weak Negative Correlation ◽  
Preliminary Study

The aim of this study is to evaluate the levels of enothelin-1 (ET-1) in children and adolescents with high myopia and its association with the axial length of the eye and the presence of myopic retinal degeneration. The cross-sectional study was carried out in 57 patients with high myopia and 29 control subjects. Serum concentrations of ET-1 were measured using enzyme-linked immunosorbent assay (ELISA) kit. A significantly lower concentration of ET-1 in highly myopic patients compared to controls was found (1.47 (0.91; 1.87) vs. 1.94 (1.1; 2.69) pg/mL, p = 0.005). In patients with high myopia, a weak negative correlation between ET-1 concentration and the longest axial length out of the two eyes was found (r = −0.255, p = 0.0558). Further analysis revealed statistically significant differences in ET-1 concentration between patients with the axial length of the eye > 26 and ≤ 26 mm (p < 0.041) and patients with the axial length of the eye > 26 mm and controls (p < 0.001). ET-1 expression is disturbed in highly myopic children and adolescents. Lower ET-1 concentration in patients with the axial length of the eye > 26 mm may co-occur with high myopia and should be considered a risk factor in the pathophysiology of high myopia progression.

scholarly journals Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial

Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Feng Bin Lin ◽  
◽  
Shi Da Chen ◽  
Yun He Song ◽  
Wei Wang ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Intraocular Pressure ◽  
High Myopia ◽  
Primary Outcome ◽  
Controlled Trial ◽  
Secondary Outcome ◽  
Rank Test ◽  
Inner Plexiform Layer ◽  
Randomized Controlled ◽  
The Impact

Abstract Background Currently, whether and when intraocular pressure (IOP)-lowering medication should be used in glaucoma suspects with high myopia (GSHM) remains unknown. Glaucoma suspects are visual field (VF) defects that cannot be explained by myopic macular changes or other retinal and neurologic conditions. Glaucoma progression is defined by VF deterioration. Here we describe the rationale, design, and methodology of a randomized controlled trial (RCT) designed to evaluate the effects of medically lowering IOP in GSHM (GSHM study). Methods The GSHM study is an open-label, single-center, RCT for GSHM. Overall, 264 newly diagnosed participants, aged 35 to 65 years, will be recruited at the Zhongshan Ophthalmic Center, Sun Yat-sen University, between 2020 and 2021. Participants will be randomly divided into two arms at a 1:1 ratio. Participants in the intervention arm will receive IOP-lowering medication, while participants in the control arm will be followed up without treatment for 36 months or until they reach the end point. Only one eye per participant will be eligible for the study. If both eyes are eligible, the eye with the worse VF will be recruited. The primary outcome is the incidence of glaucoma suspect progression by VF testing over 36 months. The secondary outcomes include the incidence of changes in the optic nerve head morphology including the retinal nerve fiber layer, and retinal ganglion cell-inner plexiform layer loss, progression of myopic maculopathy, visual function loss, and change in the quality of life. Statistical analyses will include baseline characteristics comparison between the intervention and control groups using a two-sample t-test and Wilcoxon rank sum test; generalized linear models with Poisson regression for the primary outcome; Kaplan-Meier curve and log-rank test for the incidence of the secondary outcome; and longitudinal analyses to assess trends in outcomes across time. Discussion To the best of our knowledge, the GSHM study is the first RCT to investigate the impact of medically lowering IOP in GSHM. The results will have implications for the clinical management of GSHM. Trial registration ClinicalTrials.gov NCT04296916. Registered on 4 March 2020

scholarly journals Assessment of Corneal Biomechanical Properties and Intraocular Pressure in Myopic Spanish Healthy Population

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
María A. del Buey ◽  
Laura Lavilla ◽  
Francisco J. Ascaso ◽  
Elena Lanchares ◽  
Valentín Huerva ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
High Myopia ◽  
Biomechanical Properties ◽  
Control Group ◽  
Healthy Population ◽  
Iop Measurement ◽  
Group 3 ◽  
Biomechanical Parameters ◽  
Group 2 ◽  
The Relationship

Purpose. To examine biomechanical parameters of the cornea in myopic eyes and their relationship with the degree of myopia in a western healthy population.Methods. Corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann correlated intraocular pressure (IOP), and corneal compensated IOP (IOPcc) were measured using the ocular response analyzer (ORA) in 312 eyes of 177 Spanish subjects aged between 20 and 56 years. Refraction was expressed as spherical equivalent (SE), which ranged from 0 to −16.50 diopters (D) (mean:−3.88±2.90 D). Subjects were divided into four groups according to their refractive status: group 1 or control group: emmetropia (-0.50≤SE<0.50); group 2: low myopia (-0.75≤SE<3.00 D); group 3: moderate myopia (-3.00≤SE≤-6.00 D); and group 3: high myopia (SE greater than −6.00 D). We analyzed the relationship between corneal biomechanics measured with ORA and SE.Results. CH in the emmetropia, low myopia, moderate myopia, and high myopia groups was11.13±0.98,11.49±1.25,10.52±1.54, and10.35±1.33 mmHg, respectively. CH in the highly myopic group was significantly lower than that in the emmetropic group (P=0.07) and low myopic group (P=0.035); however, there were no differences with the moderate myopic group (P=0.872). There were no statistically significant differences regarding IOP among the four groups (P>0.05); nevertheless, IOPcc was significantly higher in the moderately myopic (15.47±2.47 mmHg) and highly myopic (16.14±2.59 mmHg) groups than in the emmetropia (15.15±2.06 mmHg) and low myopia groups (14.53±2.37 mmHg). No correlation between age and the measured parameters was found. CH and IOPcc were weakly but significantly correlated with SE (r=0.171,P=0.002andr=-0.131,P=0.021, resp.).Conclusions. Present study showed only a very weak, but significant, correlation between CH and refractive error, with CH being lower in both moderately and highly myopic eyes than that in the emmetropic and low myopic eyes. These changes in biomechanical properties of the cornea may have an impact on IOP measurement, increasing the risk of glaucoma.

scholarly journals Intraocular Pressure and Glaucomatous Optic Neuropathy in High Myopia

2017 ◽  
Vol 58 (13) ◽  
pp. 5897 ◽  
Author(s):  
Jost B. Jonas ◽  
Natsuko Nagaoka ◽  
Yu Xin Fang ◽  
Pascal Weber ◽  
Kyoko Ohno-Matsui
Keyword(s):  
Intraocular Pressure ◽  
Optic Neuropathy ◽  
High Myopia ◽  
Glaucomatous Optic Neuropathy

scholarly journals PDE4B Proposed as a High Myopia Susceptibility Gene in Chinese Population

2022 ◽  
Vol 12 ◽  
Author(s):  
Fuxin Zhao ◽  
Wei Chen ◽  
Hui Zhou ◽  
Peter S. Reinach ◽  
Yuhan Wang ◽  
...  
Keyword(s):  
Protein Expression ◽  
Normal Control ◽  
High Myopia ◽  
Susceptibility Gene ◽  
A549 Cells ◽  
Dna Pooling ◽  
Myopia Progression ◽  
Expression Levels ◽  
Replication Stage ◽  
Gene And Protein Expression

Myopia is the most common cause of refractive error worldwide. High myopia is a severe type of myopia, which usually accompanies pathological changes in the fundus. To identify high myopia susceptibility genes, DNA-pooling based genome-wide association analysis was used to search for a correlation between single nucleotide polymorphisms and high myopia in a Han Chinese cohort (cases vs. controls in discovery stage: 507 vs. 294; replication stage 1: 991 vs. 1,025; replication stage 2: 1,021 vs. 52,708). Three variants (rs10889602T/G, rs2193015T/C, rs9676191A/C) were identified as being significantly associated with high myopia in the discovery, and replication stage. rs10889602T/G is located at the third intron of phosphodiesterase 4B (PDE4B), whose functional assays were performed by comparing the effects of rs10889602T/T deletion of this risk allele on PDE4B and COL1A1 gene and protein expression levels in the rs10889602T/Tdel/del, rs10889602T/Tdel/wt, and normal control A549 cell lines. The declines in the PDE4B and COL1A1 gene expression levels were larger in the rs10889602T/T deleted A549 cells than in the normal control A549 cells (one-way ANOVA, p &lt; 0.001). The knockdown of PDE4B by siRNA in human scleral fibroblasts led to downregulation of COL1A1. This correspondence between the declines in rs10889602 of the PDE4B gene, PDE4B knockdown, and COL1A1 protein expression levels suggest that PDE4B may be a novel high myopia susceptibility gene, which regulates myopia progression through controlling scleral collagen I expression levels. More studies are needed to determine if there is a correlation between PDE4B and high myopia in other larger sample sized cohorts.

Sign in / Sign up

Export Citation Format

Share Document